SCHEMBL26415525

SCHEMBL26415525

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccc(-c5ccc(N(c6ccccc6)c6ccccc6)cc5)c5oc6ccccc6c45)c4ccccc34)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.41
POLB P06746 3/20 0.41
KDM4E B2RXH2 3/20 0.41
CDC14B O60729 2/20 0.40
CDC14A Q9UNH5 2/20 0.40
MAPT P10636 9/20 0.39
NPSR1 Q6W5P4 2/20 0.38
LMNA P02545 5/20 0.37
KMT2A Q03164 5/20 0.37
TSHR P16473 3/20 0.37
HTT P42858 1/20 0.37
HPGD P15428 2/20 0.36
HSD17B10 Q99714 2/20 0.36
MAPK1 P28482 1/20 0.36
CYP17A1 P05093 1/20 0.35
CYP19A1 P11511 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
USP2 O75604 1/20 0.35
MEN1 O00255 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25057651 0.95 ALDH1A1 (0.42) ALDH1A1POLBKDM4ECDC14BCDC14A
SCHEMBL24256083 0.94 ALDH1A1 (0.41) ALDH1A1POLBKDM4ECDC14BCDC14A
SCHEMBL24255830 0.94 ALDH1A1 (0.43) ALDH1A1POLBKDM4ECDC14BCDC14A
SCHEMBL24255871 0.93 ALDH1A1 (0.42) ALDH1A1POLBKDM4ECDC14BCDC14A
SCHEMBL24255849 0.93 ALDH1A1 (0.42) ALDH1A1POLBKDM4ECDC14BCDC14A
SCHEMBL26416743 0.91 ALDH1A1 (0.37) ALDH1A1POLBKDM4ECDC14BCDC14A
SCHEMBL23821944 0.90 CDC14B (0.45) ALDH1A1POLBKDM4ECDC14BCDC14A
SCHEMBL23822419 0.90 CDC14B (0.47) ALDH1A1POLBKDM4ECDC14BCDC14A
SCHEMBL24256091 0.88 ALDH1A1 (0.38) ALDH1A1POLBKDM4ECDC14BCDC14A
SCHEMBL24255846 0.87 ALDH1A1 (0.39) ALDH1A1POLBKDM4ECDC14BCDC14A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, ORC3, ODC1 ALDH1A1 27/4885POLB 2703/4885KDM4E 3080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.